Jan 11 (Reuters) - Novartis has backed away from its pursuit of Cytokinetics, the Wall Street Journal reported on Thursday, citing sources. (Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)
Novartis drops pursuit of Cytokinetics - WSJ
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.61 CHF | -0.65% |
|
+0.46% | +13.83% |
Jan 11 (Reuters) - Novartis has backed away from its pursuit of Cytokinetics, the Wall Street Journal reported on Thursday, citing sources. (Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
96.61 CHF | -0.65% | +0.46% | 220B | ||
55.2 USD | +1.47% | +1.78% | 6.32B | ||
1st Jan change | Capi. | |
---|---|---|
+13.83% | 220B | |
+56.91% | 809B | |
+39.52% | 624B | |
-6.89% | 351B | |
+7.45% | 289B | |
+13.74% | 240B | |
-0.49% | 219B | |
+7.80% | 166B | |
-2.49% | 157B | |
+1.31% | 123B |